47 - Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma

https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/0c/e4/6b/0ce46b91-3d22-279b-52fe-d3b1a2a47107/mza_11625791986367831883.jpg/600x600bb.jpg

TMO EPM / Hemato H9J

64 episodes

4 days ago

Podcast de discussão de assuntos em Hematologia do Transplante de Medula Óssea da Escola Paulista de Medicina (UNIFESP) e da Hematologia do Hospital 9 de Julho - DASA

Medicine

Health & Fitness

RSS

All content for TMO EPM / Hemato H9J is the property of TMO EPM / Hemato H9J and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Podcast de discussão de assuntos em Hematologia do Transplante de Medula Óssea da Escola Paulista de Medicina (UNIFESP) e da Hematologia do Hospital 9 de Julho - DASA

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/38086306/38086306-1741731019354-78b838efd7422.jpg

47 - Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma

TMO EPM / Hemato H9J

32 minutes 29 seconds

8 months ago

47 - Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma

Discussão do artigo: "Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma" de Dimopoulos M NEJM 2024

Apresentado por: Dra. Thais Araujo

Discussão por: Dr. Lucas Salviano, Dr. Breno Aires, Dr. Pedro Arruda e Dr. Vinicius Molla